Registration Dossier

Administrative data

Description of key information

The test item has a LD50 >5000 mg/kg bw via oral exposure (gavage). The LD50 (oral) was determined in two OECD 401 studies with male and female rats. No other adverse effects were observed.

Key value for chemical safety assessment

Acute toxicity: via oral route

Endpoint conclusion
Endpoint conclusion:
no adverse effect observed

Acute toxicity: via inhalation route

Endpoint conclusion
Endpoint conclusion:
no study available

Acute toxicity: via dermal route

Endpoint conclusion
Endpoint conclusion:
no study available

Additional information

Justification for classification or non-classification

Based on the LD50 (oral) in rats >5000 mg/kg bw, the substance is not classifiable according to the CLP Regulation.